Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin D in HSCT
NCT03320915Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in graft-versus-host disease (GVHD) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of Chronic Graft-versus-Host Disease at 1 year. Status: unknown.
02
Drugs
vitamin d
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03320915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320915.